Biomarkers: Old-new, cardiac-noncardiac, all paving the way for better stratification in heart failure

Biomarkers in Medicine

Volumn 3, Issue 5, 2009, Pages 435-437

  Bartunek, Jozef ^a,b  

^a CARDIOVASCULAR CENTER   (Belgium)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; G PROTEIN COUPLED RECEPTOR KINASE 2; GALECTIN; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 33; ST2 PROTEIN; TROPONIN; UNCLASSIFIED DRUG;

CARDIOVASCULAR INFLAMMATION; CRITICALLY ILL PATIENT; DIAGNOSTIC VALUE; EDITORIAL; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONTRACTILITY; HUMAN; INTENSIVE CARE; LIPID METABOLISM; LUNG EMBOLISM; PROGNOSIS; TREATMENT RESPONSE;

EID: 70450231851     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/bmm.09.64     Document Type: Editorial

References (12)

1. Tang WH, Francis GS, Morrow DA et al.: National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: utilization of cardiac biomarker testing in heart failure. Circulation 116, E99-E109 (2007).
2. ESC guidelines for the diagnosis and treatment of acute and chronic heat failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association and endorsed by the European Society of Intensive Care Medicine. Eur. Heart J. 29, 2388-2442 (2008).
3. Buchner S, Jungbauer C, Birner C, Debl K, Riegger GA, Luchner A: Comparison of the cardiac markers B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide. Biomarkers Med. 3(5), 465-481 (2009).
4. Pirracchio R, Salem R, Mebazaa A: Use of B-type natriuretic peptide in critically ill patients. Biomarkers Med. 3(5), 541-547 (2009).
5. Tang WHW: Biomarkers of risk stratification in congestive heart failure: North American view. Biomarkers Med. 3(5), 443-452 (2009).
6. Jackson CE, Dalzell JR, Gardner RS: Prognostic utility of cardiac troponin in heart failure: a novel role for an established biomarker. Biomarkers Med. 3(5), 483-493(2009).
7. Dalzell JR, Jackson CE, McDonagh TA, Gardner RS: Novel biomarkers in heart failure: an overview. Biomarkers Med. 3(5), 453-463 (2009).
8. Weinberg EO: ST2 protein in heart disease: from discovery to mechanisms and prognostic value. Biomarkers Med. 3(5), 495-511 (2009).
9. Deardorff RL, Spinale FG: Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure. Biomarkers Med. 3(5), 513-523 (2009).
10. Campanile A, Iaccarino G: G-protein-coupled receptor kinases in cardiovascular conditions: focus on G-protein-coupled receptor kinase 2, a gain in translational medicine. Biomarkers Med. 3(5), 525-540 (2009).
11. Soni S, Fahuan Y, Ronco C, Cruz DN: Cardiorenal syndrome: biomarkers linking kidney damage with heart failure. Biomarkers Med. 3(5), 549-560 (2009).
12. Kamstrup PR, Nordestgaard BG: Lipoprotein(a) should be taken much more seriously. Biomarkers Med. 3(5), 439-441 (2009).